JP2018132859A - Information determination system and method, and information determination program - Google Patents

Abstract

PROBLEM TO BE SOLVED: To determine contraindication food ingredients in relation to medication information on the basis of three or more levels of contraindication degrees.SOLUTION: An information determination method comprises: an information acquisition step of acquiring information on food as a determination target to be ingested by a user and information on medication to be ingested, and attribute information on the user himself/herself; and a determination step of referring to three or more levels of combinational contraindication degrees of the food information in relation to the combination of the medication information and the attribute information to determine whether or not contraindication food ingredients are included, by the food information acquired by the information acquisition step in terms of a relation between the similarly acquired medication information and the attribute information.SELECTED DRAWING: Figure 4

Description

  The present invention relates to an information discriminating system and method, and an information discriminating program suitable for suggesting an appropriate food in relation to the user's attributes and the medicine taken by the user himself / herself.

  Conventionally, it has been known that when a specific food and a specific drug are taken at the same time, the supposed drug efficacy of the drug may be inhibited. When the patient takes these drugs without knowing the combination of so-called contraindicated drugs and foods that inhibits such drug efficacy, it becomes serious in the worst case.

  For example, avocado is generally said to be good for the body, and it is a fruit that is particularly preferred by women, but antituberculosis drugs, antiparkinsonian drugs and the like and avocado are a contraindicated combination. The component tyramine contained in avocado has the effect of increasing blood pressure, but anti-tuberculosis drugs have a function of inhibiting the decomposition of this tyramine, and when they are swallowed together, the effect of increasing the blood pressure of tyramine is enhanced. Blood pressure becomes abnormally high. Avocado contains a large amount of pyridoxine (vitamin B6), and this pyridoxine promotes the decomposition of a substance called levodopa, which is an antiparkinsonian drug, and it is said that the drug may be less effective. .

  In addition, natto is a combination that is contraindicated with each other when taking warfarin, a drug that makes blood hard to clump. That is, it is said that vitamin K made by Bacillus natto not only weakens the effect of warfarin but also makes it easier to form blood clots.

  In addition, the vitamin D3 preparation used for the treatment of osteoporosis taken by the elderly is a combination in which milk is contraindicated for each other. Vitamin D3 lumber promotes absorption of calcium from the intestinal tract and increases blood calcium, but is said to cause hypercalcemia when swallowed with milk. .

  2. Description of the Related Art Conventionally, a technique has been proposed that aims to immediately provide patients with appropriate information regarding combinations of drugs and foods that are contraindicated at an early stage (see, for example, Patent Document 1).

  According to the technology disclosed in Patent Document 1, a user includes a drug that the user is taking, a contraindicated food that is contraindicated in combination with the drug, and a contraindicated food that may be obtained by cooking the incompatible food. Obtain a contraindication database in advance. Then, the determination target food to be ingested by the user is compared with the user contraindication database to determine whether the determination target food contains a contraindicated food. As a result, if the determination target food contains contraindicated foods, a warning message is displayed to alert the user.

JP 2014-016763 A

  However, according to the technology disclosed in Patent Document 1 described above, the contraindicated food is simply specified based solely on the drug information that the user is taking. When actually determining contraindicated foods, in addition to the drug information being taken, in addition to the latest body weight, body fat percentage, blood pressure, pulse, etc. of the user, the user's age, sex, chronic disease, doctor's It is necessary to further improve the determination accuracy by including individual user attribute information such as the diagnosis result, blood glucose level, blood data, whether or not pregnant, and the presence or absence of allergy.

  In addition, the disclosed technique of Patent Document 1 is based on the premise that the determination is based on binary values indicating whether or not a food is simply contraindicated for drug information. However, there is no particular suggestion about the contraindications that indicate how contraindicated foods that are determined to be contraindicated are contraindicated. If you take the contraindicated food, there is a risk that it will become serious immediately, how high is the possibility of allergies, or in relation to the physical condition of the day, the biological information, and the attribute information, I don't know if I'm almost not worried.

  Furthermore, the contraindication of food information for combinations of drug information, attribute information, and biometric information may change according to the evolution of medicine, pharmacy, changes in cooking methods, the evolution of supplements to be taken, and changes in lifestyle There is. It is desirable to determine the contraindicated food ingredients for the drugs actually taken by the user by referring to the latest data on contraindications. With the development of big data and IoT (Internet of Things) in particular, the amount of data overflowing in the world has become much larger than before, and if these data are not used, drug information and contraindicated ingredients are contraindicated. The property cannot be updated more suitably.

  Therefore, the present invention has been devised in view of the above-described problems, and the object of the present invention is to discriminate contraindicated foods for drug information based on three or more levels of contraindications, Information discriminating system capable of discriminating not only information but also other attribute information, and further reflecting biometric information, and further judging the contraindication with reference to the latest data and A method and an information discrimination program are provided.

  The information discriminating system according to the first invention is a combination of information acquisition means for acquiring food information scheduled to be ingested by a user to be discriminated, drug information being taken, and user's own attribute information, and drug information and attribute information. The food information acquired by the information acquisition means includes a contraindicated food in relation to the drug information and the attribute information acquired in reference to the combination contraindication degree of three or more stages with the food information for And determining means for determining whether or not there is.

  The information discriminating system according to a second invention is the information discriminating system according to the first invention, wherein the information acquiring means acquires the latest biological information of the user, and the determining means includes food information for a combination of drug information, attribute information, and biological information; The food information acquired by the information acquisition means includes a contraindicated food in relation to the acquired drug information, the attribute information, and the biological information. And determining means for determining whether or not there is.

  The information discriminating system according to the third invention comprises 3 items of information acquisition means for acquiring drug information taken by the user to be determined and the user's own attribute information, and food information for the combination of drug information and attribute information. It is characterized by comprising discrimination means for discriminating contraindicated foods in relation to the drug information and the attribute information acquired by the information acquisition means with reference to the combined contraindication levels at the stages or more.

  In an information discriminating system according to a fourth invention, in the first invention, the information acquisition means acquires the latest biometric information of the user, and the discrimination means includes food information for a combination of drug information, attribute information, and biometric information. And determining means for discriminating contraindicated foods in relation to the drug information, the attribute information, and the biological information acquired by the information acquisition means. system.

  In the information discriminating system according to a fifth invention, in the first to fourth inventions, the information acquisition means is mounted on an IC card or a portable information terminal, and the discrimination means is between the IC card or the portable information terminal. It is mounted in the discriminating apparatus installed in the store which can communicate in (1).

  In any one of the first to fifth inventions, the information discrimination system according to the sixth invention is that each piece of information acquired by the information acquisition means is managed for each user on the cloud. It is managed by a server that can communicate with the determination means.

  The information discriminating system according to a seventh aspect is characterized in that, in any one of the first to sixth aspects, the discriminating means is controlled by artificial intelligence.

  In the information discriminating system according to the eighth invention, in the first or third invention, the discriminating means is provided with information relating to the relationship of food information corresponding to contraindicated foods for a combination of drug information and attribute information from the outside. It is characterized by being reflected in the combination contraindication level to be referred to.

  In the information discriminating system according to the ninth invention, in the second or fourth invention, the discriminating means is provided with information relating to the relationship of food information corresponding to contraindicated foods for a combination of drug information, attribute information and biological information from the outside. , This is reflected in the combination contraindication degree to be referred to.

  In the information discrimination system according to a tenth aspect of the present invention, in any one of the first to ninth aspects, the food information includes information related to a supplement scheduled to be ingested by a user.

  An information determination method according to an eleventh aspect of the present invention is a combination of an information acquisition step for acquiring information on food to be ingested by a user to be determined, information on medicines to be taken, and attribute information of the user, and combination of drug information and attribute information Whether or not the food information acquired in the information acquisition step contains a contraindicated food in relation to the drug information and attribute information acquired And a determining step for determining whether or not.

  The information discriminating method according to the twelfth aspect of the present invention is an information acquisition step for acquiring drug information taken by a user to be determined and the user's own attribute information, and food information for a combination of drug information and attribute information. And a discrimination step of discriminating contraindicated foods in relation to the drug information and the attribute information acquired in the information acquisition step with reference to the combined contraindication levels at the stages or more.

  An information determination program according to a thirteenth aspect of the present invention is a combination of an information acquisition step for acquiring information on food to be ingested by a user to be determined, information on a medicine to be taken, and attribute information of the user, and combination of drug information and attribute information Whether or not the food information acquired in the information acquisition step contains a contraindicated food in relation to the drug information and attribute information acquired And a determination step of determining whether or not the computer is executed.

  An information determination program according to a fourteenth aspect of the present invention is an information acquisition step for acquiring drug information taken by a user to be determined and the user's own attribute information, and food information for a combination of drug information and attribute information. The computer may execute a determination step of determining a contraindicated food in relation to the drug information acquired in the information acquisition step and the attribute information with reference to the combined contraindication levels at the stages or more.

  According to the present invention having the above-described configuration, it is possible to discriminate contraindicated foods for drug information based on three or more levels of contraindications, and to reflect not only drug information but also other attribute information and further biological information. It is possible to determine the contraindications by referring to the latest data.

It is a block diagram which shows the whole structure of the information discrimination | determination system to which this invention is applied. It is a figure which shows the structural example of the system in a store. It is a figure which shows the specific structural example of a portable information terminal. It is a flowchart of the processing operation of the information discrimination | determination system to which this invention is applied. It is a figure which shows the relationship of the contraindication degree of three or more steps of the foodstuff or supplement with respect to three categories of attribute information, chemical | medical agent information, and biometric information. It is another flowchart of the processing operation of the information discrimination | determination system to which this invention is applied. It is a flowchart in the case of updating attribute information in the processing operation of the information discrimination system to which the present invention is applied. It is a block diagram in the case of using an IC card in the information discrimination system to which the present invention is applied.

  Hereinafter, an information discrimination system 100 to which the present invention is applied will be described in detail with reference to the drawings.

  The information discriminating system 100 discriminates whether or not the food that the user intends to ingest should be ingested in relation to the user's own age, chronic illness, taking medicine, and the like.

  FIG. 1 is a block diagram showing the overall configuration of an information discrimination system 100 to which the present invention is applied. The information discriminating system 100 includes an in-store system 1, a portable information terminal 2, a hospital system 3, and a server 4. These in-store systems 1 to 4 are connected to each other via a public communication network 5.

  The public communication network 5 is an internet network or the like to which the in-store system 1 is connected via a communication line. The public communication network 5 may be a so-called optical fiber communication network. The public communication network 5 is not limited to a wired communication network, and may be realized by a wireless communication network.

  FIG. 2 is a diagram illustrating a configuration example of the in-store system 1. The in-store system 1 will be described by taking an example where the in-store system 1 is embodied as one device, but is not limited thereto, and may be embodied by a plurality of devices.

  The in-store system 1 is provided in a pharmacy where a user purchases a prescribed medicine, a drug store, a shopping mall, a supermarket, a department store, or any other store. The in-store system 1 includes an information acquisition unit 11, a communication unit 12, an input unit 13, a display unit 14, a control unit 15, an in-store database 16, and an inspection device 17.

  The information acquisition unit 11 performs non-contact communication with the portable information terminal 2, reads the personal identification ID from the portable information terminal 2, and transmits it to the control unit 15. The communication unit 12 communicates with the server 4 or the like via the public communication network 5, receives the transmitted information and supplies it to the control unit 15, or transmits the information supplied from the control unit 15.

  The input unit 13 includes a keyboard, a mouse, a touch panel, and the like, and supplies a signal corresponding to an operation of a pharmacist or the like to the control unit 15. The display unit 14 includes a liquid crystal display panel and displays various information, images, and the like based on data supplied from the control unit 15. In addition, the input unit 13 may be embodied by, for example, a barcode reader or the like, and it is possible to acquire food information that the user intends to purchase by reading a barcode attached to food or ingredients. Become.

  The control unit 15 serves as a central control unit for the operation of the entire in-store system 1. The in-store database 16 stores various data such as attribute information of each user, drug information of each user, biological information of each user, food information, and the like, and supplies these data to the control unit 15 as necessary.

  The user attribute information here refers to general personal information such as the user's age, sex, occupation, address, family, etc., as well as information diagnosed in hospitals and hospitals (hereinafter referred to as examination information), blood glucose level. Or blood data, whether or not pregnant, the presence or absence of allergies, past medical history, information on the user's DNA, etc. This attribute information can be acquired from the in-hospital system 3 as will be described later.

  The drug information of the user includes information related to a drug dispensed for the user in a pharmacy or the like, information related to a prescription of a drug issued by a doctor, and the like. This drug information includes not only information on the prescriptions that have been taken recently by the user, but also the history of medications taken in the past. Further, the medicine information includes supplements that the user wants to take in addition to the medicine, and further, the medication history. Even if the same type of supplement is used, the display of all components may differ depending on the manufacturer. In such a case, the information on the main components may be reflected in the display order.

  Furthermore, the biological information is information on a living body or health that can be measured by a person other than a doctor, such as a user's weight, body fat percentage, blood pressure, and pulse. In addition to the actual measured data, this biometric information includes questionnaires such as daily sleeping hours, smoking frequency, alcohol consumption frequency, monthly average overtime hours, family medical history, degree of fatigue, excrement status, etc. Information received from the user through a vote or through a question by a store clerk or a pharmacist is also included.

  Further, the food information is information regarding food that the user intends to consume. As this food information, for example, two types of food and food using the food may be stored in association with each other. For example, if the food is tofu, sukiyaki, mapo, miso soup, etc. may be stored in association with each other as food. In addition, if the food is natto, sushi, natto omelet, etc. may be stored in association with the food other than natto alone for rice. Further, if the ingredients are tuna, food such as sushi and seafood bowl may be stored in association with each other. Furthermore, this food information includes information on supplements that the user intends to consume.

  The inspection device 17 is a device for measuring biological information nearest to the user. The inspection device 17 is configured by a device that can easily measure biological information at a store such as a drug store, such as a weight scale, a body fat percentage measuring device, a blood pressure meter, and a pulse meter. The inspection device 17 is connected to the control unit 15, and the measured biological information is sent to the control unit 15. The control unit 15 performs control so that the biological information acquired from the inspection device 17 is stored in the in-store database 16. The inspection device 17 may be constituted by a reader that can electrically read a questionnaire in the form of a mark sheet that has been answered by the user regarding biometric information. Further, when the store clerk or the pharmacist hears biometric information directly from the user, the biometric information is input via the input unit 13 described above, and the biometric information is supplied from the input unit 13 to the control unit 15. Good.

  The mobile information terminal 2 is, for example, a mobile phone, a smartphone, a tablet terminal, a wearable terminal, a notebook personal computer (PC), or the like, and a device that can communicate via the public communication network 5 based on at least a user operation. It is. The portable information terminal 2 is a device that can be carried by the user at all times. However, the portable information terminal 2 is not limited to this, and is a concept including all electronic devices such as a stationary desktop PC. It is.

  The portable information terminal 2 communicates via the public communication network 5 when installing package software sold at a store without downloading an information determination program to be described later via the public communication network 5. It may be a device that does not perform. In the following example, a case where a smartphone is applied to the portable information terminal 2 will be described as an example.

  FIG. 3 shows a specific configuration example of the portable information terminal 2. The portable information terminal 2 includes a ROM (Read Only Memory) 22, a RAM (Random Access Memory) 23 as a work area used for storing and developing data, and a CPU (control unit) for controlling the entire portable information terminal 2. Central Processing Unit) 24, an operation unit 25 for inputting various control commands via operation buttons, a keyboard, and the like, an output I / F 36 for controlling display of various information, a hard disk, and the like. A storage unit 27 for storing a program for performing a search to be executed and data for inputting data from the outside into the portable information terminal 2 or outputting data generated in the portable information terminal 2 to the outside A data input / output unit 29 is connected to the internal bus 21. Further, a communication I / F 28 and a proximity communication unit 31 are connected to the internal bus 21. The output I / F 36 is connected to a display unit 26 as a monitor that actually displays information.

  The ROM 22 stores a program for controlling hardware resources of the portable information terminal 2 as a whole. The RAM 23 temporarily stores various commands for controlling the hardware resources of the entire portable information terminal 2.

  The CPU 24 is a so-called central processing unit for controlling each component mounted in the portable information terminal 2 by transmitting a control signal via the internal bus 21. Further, the CPU 24 transmits various control commands via the internal bus 21 in accordance with user operations via the operation unit 25.

  The operation unit 25 is embodied by a touch panel or the like, and information related to a problem that the user wants to solve is input, and an execution command for executing the program according to the present invention is input from the user. When the execution command is input by the user, the operation unit 25 notifies the CPU 24 of this. Upon receiving this notification, the CPU 24 reads the program from the storage unit 27 and executes it.

  The output I / F 36 includes a graphic controller that creates a display image based on control by the CPU 24. The display unit 26 connected to the output I / F 36 is realized by, for example, a liquid crystal display (LCD).

  When the storage unit 27 is composed of a hard disk, based on control by the CPU 24, predetermined information is written to each address and read out as necessary. The storage unit 27 stores a program for executing the present invention. This program is read by the CPU 24 and executed. The storage unit 27 may store attribute information, drug information, biometric information, and the like.

  The communication I / F 28 is mounted with a line control circuit for connecting to the public communication network 5, a signal conversion circuit for performing data communication with other terminal devices, and the like. The communication I / F 28 converts various commands from the internal bus 21 and sends them to the public communication network 5 side. When receiving data from the public communication network 5, the communication I / F 28 performs predetermined conversion processing on the received data. To the internal bus 21 or the CPU 24.

  The data input / output unit 29 is connected to a cord or the like for USB connection with an electronic device such as a PC. Data can be input / output to / from an external device via the data input / output unit 29.

  The proximity communication unit 31 performs non-contact communication with the in-store system 1 and the in-hospital system 3, transmits a personal identification ID, and transmits / receives necessary information.

  The in-hospital system 3 is provided in a hospital where a user who is a patient visits. The in-hospital system 3 reads the personal identification ID from the portable information terminal 2 by proximity communication such as non-contact communication with the proximity communication unit 31 in the portable information terminal 2 and performs various input processes according to an input operation by a doctor or the like. Do.

  Further, in the hospital system 3, personal information of a user who is a patient and medical examination information generated in the hospital and related hospitals are recorded for each user.

  The in-hospital system 3 converts the user's personal information and the doctor's examination information as the above-described attribute information as necessary, and transmits the attribute information to the server 4 and the in-store system 1 via the public communication network 5.

  The server 4 has a predetermined database. In this database, information (including food information, attribute information, drug information, biometric information, etc.) sent via the public communication network 5 is accumulated. In addition, the server 4 sends the stored information via the public communication network 5 to the in-store system 1, the portable information terminal 2, the in-store system 1, the portable information terminal 2, and the in-hospital system 3. Send to hospital system 3.

  Note that any one or more components in the in-store system 1, the portable information terminal 2, the in-hospital system 3, and the server 4 may be controlled by artificial intelligence. The specific application method of artificial intelligence to the present invention may be based on any one or more of all known information related to artificial intelligence.

  The information discriminating system 100 to which the present invention is applied is executed via an information discriminating program installed in the in-store system 1, the portable information terminal 2, the in-hospital system 3, and the server 4. That is, the user operates the portable information terminal 2 or through the suggestion displayed through the processing operation by the in-store system 1, the user's own age, chronic illness, taking medicine, etc. It is discriminated whether or not it should be taken in the relationship. The information discriminating program is not limited to the case where it is installed and used in the portable information terminal 2, but is stored and operable in the in-store system 1, the in-hospital system 3, and the server 4, and the portable information terminal 2 side Of course, these may be accessed and used.

  FIG. 4 shows an example of a processing operation flow of the information discrimination system 100 to which the present invention is applied.

  First, it is assumed that attribute information has already been input into the user's portable information terminal 2 before the start of the system. This attribute information may be stored in the in-store database 16 in the server 4 or the in-store system 1 or the in-hospital system 3 in a state in which confidentiality is ensured through a user ID or the like.

Under such a state, first, in step S11, the user is asked to issue a location when visiting the hospital. When issuing the location information, the in-hospital system 3 transfers the drug information to the user's portable information terminal 2 by proximity communication such as non-contact communication, in addition to printing the drug information on a paper medium and delivering it to the user. Thereby, the medicine information in the portable information terminal 2 is updated (step S12). When the medicine information on the paper medium is issued, the user may input the medicine information via the voice input / output unit 31 or the operation unit 25. In such a case, the medicine in the portable information terminal 2 is similarly applied. Information will be updated.

  After the end of step S12, in the storage unit 27 of the portable information terminal 2, medicine information is input in addition to the attribute information. The drug information stored in the storage unit 27 includes not only drug information based on the newly issued location in step S11 but also a history of medication based on a location issued before this time. All may be entered.

  In step S12, the user who has updated the drug information in the portable information terminal 2 moves to a store such as a drug store, and accesses the in-store system 1 via a store clerk or a pharmacist if necessary. In this in-store system 1, the portable information terminal 2 is caused to perform proximity communication with the information acquisition unit 11. Thereby, the in-store system 1 can acquire the drug information and the attribute information input to the portable information terminal 2 (step S21). The in-store system 1 temporarily stores the acquired drug information and attribute information in the in-store database 16.

  Next, it transfers to step S22 and biometric information is measured. The biometric information is measured using an inspection device 17 installed in the store. A store clerk or a pharmacist measures a user's weight, body fat percentage, blood pressure, pulse, and the like using a weight scale, a body fat percentage measuring device, a blood pressure meter, a pulse meter, and the like. The measured biological information is temporarily stored in the in-store database 16. Note that step S22 may be performed prior to step S21.

  Next, it transfers to step S23 and the control part 15 discriminate | determines the foodstuff with a high contraindication degree. In determining the repellent degree, the in-store system 1 holds data on the contraindication levels of three or more levels of foods or supplements for three categories of attribute information, drug information, and biological information as shown in FIG. It shall be. This attribute information includes, for example, “age” classified by age, “sex” classified by gender, “disease, allergies” classified by specific chronic diseases and allergies, and blood glucose levels. For example, “blood glucose level” is defined. Similarly, as the attribute information, “antituberculosis drug”, “antiparkinsonian drug”, “warfarin”, “vitamin D3”, and the like are classified. In addition, as biometric information, “BMI (body mass index)”, “body fat percentage”, “blood pressure”, “pulse”, and the like classified in numerical ranges are defined.

  Further, examples of contraindicated food ingredients include “natto”, “egg”, “milk”, “tuna”, etc., and foods using the respective ingredients may be stored in association with each other. Moreover, the contraindicated foodstuff is not limited to the case embodied in what is called a food, and a supplement is also contained in this. In such a case, for example, “vitamin C” or “concentrated turmeric” may be defined as the substance instead of the food, and the product name of the supplement using the substance may be stored in association with it.

  As shown in FIG. 5, the contraindication data is organized by an association model in which attribute information, drug information, and biological information are arranged on the left side and contraindication food candidates are arranged on the right side. In this association degree model, each classification of attribute information, each classification of drug information, and each classification of biological information is defined as a contraindication degree of three or more levels with food (substance). This means that foods (supplements) containing foodstuffs (substances) with high contraindication values are highly contraindicated. High contraindications mean that if you take food (supplements) containing ingredients (substances) that have been determined to be more contraindicated, there is a high possibility that some risk will arise for your health. Is meant to be. This health risk means all symptoms that impair health, such as increased blood pressure, thrombus, nausea, hypercalcemia, attraction, and diarrhea.

  In the present invention, for each food, it is premised that one or more types of attribute information, one or more types of drug information, and one or more types of biological information have a contraindication degree. For example, in natto as a food ingredient, “age” is defined as one type of attribute information, “antiparkinsonian drug” is defined as one type of drug information, and “blood pressure” is defined as the contraindication level as biometric information. Yes. At this time, for example, “Natto” has a contraindication level (25%, 35%, 50%, 60%) for each classification of “age” (under 30s, 40s, 50s, 60s, 70s and over) , 75%). Similarly, the contraindication level (15%, 25%, 30%, etc.) for each classification of “blood pressure” (less than 120, less than 120 to 130, less than 130 to 140, less than 140 to 160, 160 or more) with respect to “natto” (40%, 55%). Similarly, the contraindication degree of “antiparkinsonian drug” is assigned to “natto” as 60%.

  As described above, three or more levels of contraindication may be assigned for each category for one or more items of attribute information, drug information, and biometric information for the food, but these attribute information, drug information, and biometric information may be assigned. The contraindication level for the combination (hereinafter referred to as the combination contraindication level) may be assigned to the food.

  In this case, for example, a combination of “natto” for three combinations of “age” as attribute information in the 60s, “antiparkinsonian drug” as drug information, and “blood pressure” as biometric information less than 140 to 160 Concomitant use of “Natto” for three combinations with 55% contraindication, “age” as attribute information in 40s, “antiparkinsonian drug” as drug information, and “blood pressure” as biometric information less than 120-130 The combination contraindication degree of “Natto” for three combinations of 25%, “age” as attribute information is over 70s, “antiparkinsonian drug” as drug information, and “blood pressure” as biometric information is 160 or more It may be assigned as 85% or the like.

  Furthermore, in constructing the contraindication level of the combination of attribute information, drug information, and biometric information, two or more types may be set in the attribute information, or two or more types may be set in the drug information. It may be set as a spanning combination item, or may be set as a combination item across two or more types in the biological information. For example, “Natto” for a combination in which “age” as attribute information is in the 60s and “blood glucose level” is 126 or more, “anti-Parkinson drug” as drug information, and “BMI” as biometric information is less than 35-40 May be assigned such that the combination contraindication degree of “is 65% or the like. Also, the combination contraindication degree of “concentrated turmeric” for the combination of “disease, allergy” as attribute information, “warfarin” and “antituberculosis drug” as drug information, and “pulse” as biometric information exceeding 100 May be assigned such as 45%. Furthermore, the sex as the attribute information is “female”, the drug information is “warfarin” and “vitamin D3”, the “BMI” is less than 18.5, the blood pressure is 160 or more, and the pulse is 60-100. The combination contraindication degree of “egg” with respect to the combination of may be assigned such as 80%.

  The in-store system 1 determines the food (foodstuff) in step S23 after acquiring in advance three or more levels of combination contraindication shown in FIG. In such a case, under the control of the control unit 15, referring to the combination contraindication levels of three or more stages shown in FIG. 5 from the user attribute information, drug information, and biological information acquired before step S 22, Determine.

  For example, “age” as user attribute information acquired in step S22 is in his 60s and “blood glucose level” is 126 or more, “anti-parkinsonian drug” as drug information, and “BMI” as biometric information is 35. If it is less than ˜40, it is possible to determine that “natto” is 65% when referring to the above-mentioned combination contraindication, such as “curry rice” is 34%, “vitamin C” is 19%, etc. Thus, the combination contraindication degree for each food (foodstuff) can be determined. Similarly, the sex as the user attribute information acquired in step S22 is “female”, the drug information is “warfarin” and “vitamin D3”, “BMI” is less than 18.5, and the blood pressure is 160 or more. And when the pulse is 60 to 100, when referring to the combination contraindications described above, it can be determined that “egg” is 80%, “celery” is 10%, “scallop” is 6%, etc. .

  Furthermore, the drug information includes information about supplements that the user is taking. For this reason, when folic acid, zinc, or the like is selected as a supplement in the drug information, it is possible to determine the degree of contraindication of combination of food supplements with these supplements, attribute information, and biometric information.

  For example, when “age” as attribute information of the acquired user is in his 30s, “folic acid” as a supplement as drug information, and “BMI” as biometric information is less than 35 to 40, the combination contraindication degree described above is set. When referred to, it is possible to determine that “natto” is 45%, and it is possible to determine the combination contraindication level for each food (foodstuff) and supplement such that “vitamin C” is 56%. In particular, when a supplement is selected as drug information and a supplement is selected as a food material, it is possible to determine the contraindications between the supplements.

  The in-store system 1 may notify the user of the combination contraindication degree determined in this way by any method. In such a case, for example, the foodstuff (substance) having a high combination contraindication level, and thus the food (supplement) associated therewith may be displayed together with the combination contraindication level via the display unit 14 or a receipt. You may make it display them on paper media, such as. Alternatively, the high contraindication food (substance) or food (supplement) may be notified by transmitting it to the user's portable information terminal 2 via the communication unit 12 or the information acquisition unit 11 together with the combination contraindication. Good.

  A user who has confirmed such a combination contraindication level can determine a highly contraindicated food from the relationship between the biological information measured today and the drug information on the drug currently ingested, in addition to his attribute information. . As a result, it is possible to avoid the purchase of foods containing foodstuffs having high contraindications in advance, and it is possible to avoid health problems due to ingestion of foodstuffs having high contraindications. In particular, it may be dangerous to take a drug and a supplement. However, according to the present invention, the contraindication is defined by combining the drug information and the food information including the supplement. Can also be performed.

  FIG. 6 shows another example of the processing operation flow of the information discrimination system 100 to which the present invention is applied. In this processing operation flow, the same step as the processing operation flow shown in FIG. 4 described above is given the same step number S, and the description below is omitted.

  The processing operation shown in FIG. 6 is different in that the process proceeds to step S24 after the acquisition of the drug information and attribute information in step S21 and the acquisition of the biological information in step S22 are completed. That is, in this step S24, the user selects ingredients for purchase in the store. When a store is a drug store, a supermarket, or a shopping mall, foodstuffs, and by extension, foods that use them are displayed, and the user can often select them for purchase. For example, it can be considered that the food or food put in the shopping cart is selected for purchase by the user to be taken by himself / herself. In the in-store system 1, food information can be read from a food or food put in a shopping cart via a barcode reader as the input unit 13, or an IC tag reading device embodied in the information acquisition unit 11 The food information can be read through. Incidentally, the selection of the ingredients may be other than the store where the in-store system 1 is installed. Thus, after acquiring the food information about the foodstuff and foodstuff which the user selected on the in-store system 1 side, it transfers to step S25.

  In addition, this step S24 may change order between step S21 and S22. In other words, it is only necessary to obtain attribute information, drug information, biological information, and food information through steps S21, 22, and 24 before reaching step S25.

  When the process proceeds to step S25, the contraindication is determined including the food information acquired in step S24 in addition to the acquired attribute information, drug information, and biological information. The determination in step S25 is mainly for determining the level of contraindication in relation to attribute information, drug information, and biological information for the food and ingredients selected by the user for purchase in step S24.

  In such a case as well, the degree of association with the ingredients with respect to the attribute information, drug information, and biological information as shown in FIG. 5 is referred to. The in-store system 1 makes a determination in step S25 after acquiring in advance three or more combinations of contraindications shown in FIG. In such a case, under the control of the control unit 15, referring to the combination contraindication levels of three or more stages shown in FIG. 5 from the user attribute information, drug information, biological information, food information acquired before step S 24, Identify contraindicated ingredients.

  For example, “age” as user attribute information acquired in step S22 is in his 60s and “blood glucose level” is 126 or more, “anti-parkinsonian drug” as drug information, and “BMI” as biometric information is 35. When it is less than ˜40 and the ingredient selected by the user is “tuna”, it can be determined that it is 25% when the above-mentioned combination contraindication is referred to. For example, when the “blood glucose level” is 126 or more, the drug information is “anti-Parkinson's disease drug”, the biometric information is “BMI” is less than 35 to 40, and the ingredient selected by the user is “natto” In addition, when the above-mentioned combination contraindication is referred to, it can be determined that it is 75%. For example, the “blood glucose level” is 126 or more, the drug information is “anti-Parkinson's disease drug”, the biometric information is “BMI” is less than 35-40, and the food material selected by the user is “vitamin C”. In this case, when the combination contraindication level described above is referred to, it can be determined that it is 45%.

  Thus, even if attribute information, medicine information, and biometric information are the same combination, the combination contraindication levels of the ingredients are individually set. For this reason, the combination contraindication levels determined in accordance with the food selected by the user may be different from each other.

  In addition to the above, the same applies when two or more types of attribute information, drug information, and biological information are selected. For example, the sex as the user attribute information acquired in step S22 is “female”, the drug information is “warfarin” and “vitamin D3”, “BMI” is less than 18.5, and the blood pressure is 160 or more, In addition, when the pulse is 60 to 100 and the selected food is “egg”, when the combination contraindication degree described above is referred to, “egg” is 80%, so this is notified to the user.

  The in-store system 1 may notify the user of the combination contraindication degree determined in this way by any method. In such a case, for example, the numerical value of the combination contraindication may be displayed via the display unit 14 or may be displayed on a paper medium such as a receipt. Or you may make it discriminate | determine through the threshold value for classifying a combination contraindication degree into two or more steps, and display the discrimination | determination result.

  As described above, the information discriminating system 100 to which the present invention is applied is characterized in that discrimination regarding the contraindication of food is performed through the combination contraindication levels set in three or more stages. The combination contraindication degree can be described by a numerical value of, for example, 0 to 100%, but is not limited to this, and may be configured at any stage as long as it can be described by three or more numerical values. .

  By searching based on the combination contraindication levels expressed by numerical values of three or more levels, even if the same kind of combination among attribute information, drug information, and biological information is used, a plurality of ingredients (food) It is also possible to search and display in descending order of combination contraindications. Thus, if it can display to a user in order with a high combination contraindication degree, the suggestion which can preferentially avoid purchase of a more dangerous foodstuff can be given.

  In addition to this, according to the present invention, it is possible to judge an extremely low foodstuff (food) with a combined contraindication level of 1% without missing it. Even if ingredients (food) with extremely low contraindications are connected as a small sign, it may be a risk that health may be impaired once every tens or hundreds of times. You can call attention to it.

  Furthermore, according to the present invention, there is a merit that a search policy can be determined in a manner of setting a threshold by searching for foods having high contraindication properties based on such combined contraindication levels of three or more stages. . If the threshold value is lowered, even if the combination contraindication level is 1%, it can be picked up without omission, but on the other hand, a lot of food (food) with low risk may be picked up. On the other hand, if the threshold value is increased, only high-risk foods (food) can be narrowed down, while foods that have low risk but sometimes cause harmful effects may be overlooked. It is possible to decide which to place importance on the basis of the idea on the user side and the system side, but it is possible to increase the degree of freedom in selecting points to place such emphasis.

  The present invention is not limited to the embodiment described above. For example, a processing operation flow as shown in FIG. 7 may be executed. In the processing operation flow of FIG. 7, the same steps as the processing operation flows shown in FIGS. 4 and 6 described above are given the same step number S, and the following description is omitted.

  In the processing operation flow shown in FIG. 7, in the hospital system 3, the user first receives a diagnosis by a doctor in step S13. And it transfers to step S14 and the information regarding the illness diagnosed by the doctor, the given treatment, and medication is reflected in the attribute information of the user. As a result, the attribute information is updated to the latest one reflecting the diagnosis and treatment of the doctor on that day. This step S14 is followed by step S11.

  The in-store system 1 is followed by steps S21, S22, S24, and S25 as in the processing operation of FIG. 6, but is not limited to this, and steps S21, S22, and S23 are performed as shown in FIG. It may follow.

  In the above-described embodiment, the description has been made on the assumption that at least one item is selected from the attribute information, drug information, and biological information. However, the present invention is not limited to this. At least one item may be selected from the information and drug information. In such a case, it is only necessary that the combination relation to be referred to shown in FIG. 5 is set in relation to the attribute information, the drug information, and the food material, and the biological information may not be particularly included. In such a case, step S22 for measuring biological information is omitted.

  In the above-described embodiment, the case where attribute information, drug information, biological information, and eventually food information are collected in the in-store system 1 and the combination contraindication level is determined is described as an example. However, the present invention is not limited thereto. Is not to be done. For example, when the server 4 or the cloud side manages all attribute information, drug information, biometric information, food information, or any one or more for each user and determines the combination contraindication level, the in-store system 1 Such information may be acquired by accessing the server 4 or the cloud.

  Further, in the present invention, for example, the above-described determination may be performed via an application operating on the portable information terminal 2 possessed by the user or a personal computer (PC) other than the in-store system 1. In such a case, the processing operation described above is executed through the application program installed in the portable information terminal 2 or the PC. In such a case as well, all or any one or more of attribute information, drug information, biological information, and food information may be acquired in the portable information terminal 2 or the PC. Alternatively, when the server 4 or the cloud side manages all attribute information, drug information, biological information, food information, or any one or more for each user and determines the combination contraindication level, the portable information terminal 2 or Such information may be acquired by accessing the server 4 or the cloud from a PC.

  Incidentally, the portable information terminal 2 can be replaced with an IC card or the like. FIG. 8 shows an example in which the portable information terminal 2 is replaced with an IC card 20. The IC card 20 includes a communication unit capable of short-range communication between an IC tag capable of recording information and a wireless communication unit capable of transmitting and receiving information via the public communication network or the information acquisition unit 11. Yes. Similarly to the portable information terminal 2, the IC card 20 can transmit and receive information with the in-store system 1 and the in-hospital system 3. Attribute information is stored in advance in the IC card 20, and may be updated in step S14 or the like as necessary. Further, the drug information is updated in the IC card 20 in step S12. These information updates are executed via a communication unit or the like in the IC card 20. Further, the in-store system 1 acquires attribute information and drug information from the IC card 20 through the information acquisition unit 11 in step S21. The processing operation using the IC card 20 can be described by replacing all the processing operations of the portable information terminal 2 described above with the IC card 20.

  Furthermore, in the present invention, the above-mentioned combination contraindication level may be updated. That is, the combination contraindication level of attribute information, drug information, biometric information, and ingredients as shown in FIG. 5 is updated as needed. For example, this update may reflect information provided via the public communication network 5. When new knowledge about the contraindications between attribute information, drug information, biological information, and ingredients is discovered through site information or writing that can be obtained from the public communication network 5, the combined contraindication degree according to the knowledge Is raised or lowered. For example, when it is newly reported that contraindications are high in relation to a certain food item and a certain type of item in attribute information, drug information, or biometric information, the combination set between them Increase the degree of contraindications. In addition, if it is newly reported that the contraindication is low in the relationship between a certain type of item in attribute information, drug information, and biometric information and a specific food, the combination set between these Decrease contraindications.

  This combination contraindication level is updated based on research data and papers by doctors and dietitians, as well as on the contents of conference presentations by the system side or the user side, or automatically, in addition to the case where it is based on information obtainable from the public communication network 5. You may make it update automatically. Artificial intelligence may be used in these update processes.

  That is, according to the present invention, when information related to the relationship of food information corresponding to contraindicated foods for combinations of drug information and attribute information is provided from the outside, this is reflected in the combination contraindication level to be referred to. May be. Similarly, when information related to the relationship of food information corresponding to contraindicated foods for a combination of drug information, attribute information, and biometric information is provided from the outside, this may be reflected in the combination contraindication level to be referred to .

DESCRIPTION OF SYMBOLS 1 In-store system 2 Portable information terminal 3 In-hospital system 4 Server 5 Public communication network 11 Information acquisition part 12 Communication part 13 Input part 14 Display part 15 Control part 16 In-store database 17 Inspection equipment 21 Internal bus 25 Operation part 26 Display part 27 Storage Unit 29 Data Input / Output Unit 31 Voice Input / Output Unit 31 Proximity Communication Unit 36 Output I / F
100 Information discrimination system

The information determination system according to the first aspect of the present invention is an information acquisition means for acquiring food information scheduled to be ingested by a user to be determined and drug information being taken, user's own attribute information, and biometric information closest to the user. The food information acquired by the information acquisition means is the same as the acquired drug information, the attribute, with reference to the combination contraindication levels of three or more stages with the food information for the combination of the drug information, the attribute information, and the biological information. And a discriminating means for discriminating whether or not a contraindicated food is contained in relation to the information and the biological information .

An information determination system according to a second aspect of the present invention includes an information acquisition means for acquiring drug information taken by a user to be determined, the user's own attribute information, and the most recent biological information of the user , drug information, and attribute information. and refers to the three stages or more combinations contraindications of the food information for a combination of biological information, the agent information acquired by the information acquisition means determines contraindicated ingredients in relation to the attribute information and the biometric information determiner Means.

An information determination system according to a sixth aspect of the present invention is a combination of information acquisition means for acquiring food information scheduled to be ingested by a user to be determined, information on medicines to be taken, and user's own attribute information, and drug information and attribute information The food information acquired by the information acquisition means includes a contraindicated food in relation to the drug information and the attribute information acquired in reference to the combination contraindication degree of three or more stages with the food information for A determination means for determining whether or not the information includes a relationship between food information corresponding to the contraindicated ingredients for the combination of the drug information and the attribute information provided from the outside, and a combination contraindication degree to which this should be referred It is characterized by being reflected in .

The information discriminating system according to the seventh invention includes information acquisition means for acquiring drug information taken by the user to be determined and the user's own attribute information, and food information for the combination of the drug information and attribute information. A discrimination means for discriminating contraindicated foods in relation to the drug information acquired by the information acquisition means and the attribute information, with reference to the combination contraindication level at the stage or more, and the discrimination means includes drug information and attribute information Information regarding the relationship of food information corresponding to the contraindicated food ingredients for the combination is provided from the outside, and this is reflected in the combination contraindication level to be referred to .

An information determination method according to a tenth aspect of the present invention is an information acquisition step of acquiring food information scheduled to be ingested by a user to be determined and drug information being taken, user's own attribute information, and user's latest biological information. , drug information, with reference to three steps or more combinations contraindications of the food information for a combination of the attribute information and the biological information, the food information acquired in the information acquisition step, also obtained the medicine information, and the attribute information And a determination step of determining whether or not a contraindicated food is contained in relation to the biological information .

Information determination method according to the eleventh invention, the drug information that the user of the determination target is taking, the attribute information of the user himself, and the information acquisition step of acquiring the latest biometric information of the user, medication information, attribute information And a discrimination step for discriminating contraindicated foods in relation to the drug information, the attribute information, and the biological information acquired in the information acquisition step with reference to three or more combinations of contraindications with food information for the combination of biological information It is characterized by having.

An information determination method according to a twelfth aspect of the present invention includes an information acquisition step of acquiring food information scheduled to be ingested by a user to be determined, information on a medicine to be taken, and user's own attribute information, and a combination of drug information and attribute information Whether or not the food information acquired in the information acquisition step contains a contraindicated food in relation to the drug information and attribute information acquired In the determination step, information on the relationship of food information corresponding to the contraindicated ingredients for the combination of drug information and attribute information is provided from the outside, and the combination contraindication level to be referred to It is characterized by reflecting .

The information discriminating method according to the thirteenth invention comprises 3 information acquisition steps for acquiring drug information taken by the user to be determined and the user's own attribute information, and food information for the combination of the drug information and attribute information. A combination step of referring to the combination contraindication level at a stage or more and determining a contraindicated food in relation to the drug information and the attribute information acquired in the information acquisition step. In the determination step, the drug information and the attribute information Information regarding the relationship of food information corresponding to the contraindicated food ingredients for the combination is provided from the outside, and this is reflected in the combination contraindication level to be referred to .

An information determination program according to a fifteenth aspect of the present invention is an information acquisition step for acquiring food information scheduled to be ingested by a user to be determined and drug information being taken, the user's own attribute information, and the user's latest biological information. , drug information, with reference to three steps or more combinations contraindications of the food information for a combination of the attribute information and the biological information, the food information acquired in the information acquisition step, also obtained the medicine information, and the attribute information And a determination step of determining whether or not a contraindicated food is contained in relation to the biological information .

An information determination program according to a sixteenth aspect of the invention is an information acquisition step for acquiring drug information taken by a user to be determined, the user's own attribute information, and the most recent biological information of the user , drug information, and attribute information And a discrimination step for discriminating contraindicated foods in relation to the drug information, the attribute information, and the biological information acquired in the information acquisition step with reference to three or more combinations of contraindications with food information for the combination of biological information And making the computer execute.

An information determination program according to a seventeenth aspect of the present invention is a combination of an information acquisition step for acquiring information on food to be ingested by a user to be determined, information on medicines to be taken, and user's own attribute information, and combination of drug information and attribute information Whether or not the food information acquired in the information acquisition step contains a contraindicated food in relation to the drug information and attribute information acquired In the determination step, information on the relationship of food information corresponding to the contraindicated ingredients for the combination of drug information and attribute information is provided from the outside, and the combination contraindication level to be referred to It is characterized by having a computer execute reflecting .

According to an eighteenth aspect of the present invention, there is provided an information determination program comprising: an information acquisition step of acquiring drug information taken by a determination target user; and the user's own attribute information; and food information for a combination of drug information and attribute information. A combination step of referring to the combination contraindication level at a stage or more and determining a contraindicated food in relation to the drug information and the attribute information acquired in the information acquisition step. In the determination step, the drug information and the attribute information Information regarding the relationship of the food information corresponding to the contraindicated food ingredients for the combination is provided from the outside, and the computer is caused to reflect the information on the combination contraindication level to be referred to .

The information determination system according to the first aspect of the present invention is an information acquisition means for acquiring food information scheduled to be ingested by a user to be determined and drug information being taken, user's own attribute information, and biometric information closest to the user. The food information acquired by the information acquisition means is the same as the acquired drug information, the attribute, with reference to the combination contraindication levels of three or more stages with the food information for the combination of the drug information, the attribute information, and the biological information. Determining means for determining whether or not a contraindicated food is included in relation to the information and the biological information, and the determining means is food information corresponding to a contraindicated food for a combination of drug information, attribute information, and biological information Information on the relationship between the two is provided from the outside and is reflected in the combination contraindication level to be referred to .

An information determination system according to a second aspect of the present invention includes an information acquisition means for acquiring drug information taken by a user to be determined, the user's own attribute information, and the most recent biological information of the user, drug information, and attribute information. Discriminating to discriminate contraindicated foods in relation to the drug information, the attribute information and the biological information acquired by the information acquisition means with reference to the combination contraindication levels of three or more levels with food information for the combination of biometric information Information on the relationship of the food information corresponding to the contraindicated ingredients for the combination of drug information, attribute information and biological information is provided from the outside, and this is reflected in the combination contraindication level to be referred to It is characterized by.

An information determination method according to a sixth aspect of the present invention is an information acquisition step of acquiring food information scheduled to be ingested by a user to be determined and drug information being taken, user's own attribute information, and user's latest biological information. The food information acquired in the information acquisition step is the same as the acquired drug information, the attribute information, A determination step for determining whether or not a contraindicated food is included in relation to the biological information, and in the determination step, the food information corresponding to the contraindicated food for the combination of drug information, attribute information, and biological information is included. Information on the relationship is provided from the outside, and this is reflected in the combination contraindication to be referred to .

An information determination method according to a seventh aspect of the present invention is an information acquisition step for acquiring drug information taken by a determination target user, the user's own attribute information, and the most recent biological information of the user, drug information, and attribute information And a discrimination step for discriminating contraindicated foods in relation to the drug information, the attribute information, and the biological information acquired in the information acquisition step with reference to three or more combinations of contraindications with food information for the combination of biological information In the determination step, information relating to the relationship of the food information corresponding to the contraindicated food ingredients for the combination of drug information, attribute information and biometric information is provided from the outside, and this is reflected in the combination contraindication level to be referred to It is characterized by.

An information determination program according to an eighth aspect of the present invention is an information acquisition step for acquiring food information scheduled to be ingested by a user to be determined and drug information being taken, user's own attribute information, and user's latest biological information; The food information acquired in the information acquisition step is the same as the acquired drug information, the attribute information, A determination step for determining whether or not a contraindicated food is included in relation to the biological information, and in the determination step, the food information corresponding to the contraindicated food for the combination of drug information, attribute information, and biological information is included. information on the relationship may be provided externally, executed by a computer to be reflected in combination contraindications degree to be referred to this And characterized in that.

An information determination program according to a ninth aspect of the present invention is an information acquisition step for acquiring drug information taken by a determination target user, the user's own attribute information, and the user's latest biological information, drug information, and attribute information And a discrimination step for discriminating contraindicated foods in relation to the drug information, the attribute information, and the biological information acquired in the information acquisition step with reference to three or more combinations of contraindications with food information for the combination of biological information In the determination step, information relating to the relationship of the food information corresponding to the contraindicated food ingredients for the combination of drug information, attribute information and biometric information is provided from the outside, and this is reflected in the combination contraindication level to be referred to and characterized by causing a computer to execute the.

An information determination method according to a sixth aspect of the present invention is an information acquisition step of acquiring food information scheduled to be ingested by a user to be determined and drug information being taken, user's own attribute information, and user's latest biological information. The food information acquired in the information acquisition step is the same as the acquired drug information, the attribute information, A determination step for determining whether or not a contraindicated food is contained in relation to the biological information, and the computer executes each of the steps, and in the determination step, a combination of drug information, attribute information, and biological information Information on the relationship of food information corresponding to contraindicated food ingredients is provided externally, and this contradicts the degree of combination contraindication that should be referred to Characterized in that to.

An information determination method according to a seventh aspect of the present invention is an information acquisition step for acquiring drug information taken by a determination target user, the user's own attribute information, and the most recent biological information of the user, drug information, and attribute information And a discrimination step for discriminating contraindicated foods in relation to the drug information, the attribute information, and the biological information acquired in the information acquisition step with reference to three or more combinations of contraindications with food information for the combination of biological information The computer executes each of the above steps, and in the determining step, information relating to the relationship of the food information corresponding to the contraindicated ingredients for the combination of the drug information, the attribute information, and the biological information is provided from the outside. It is characterized by reflecting the degree of contraindications to be combined.

Claims (14)

Information acquisition means for acquiring information on the food to be ingested by the user to be discriminated and information on the medicine taken and the attribute information of the user himself;
Referencing the combination contraindications of three or more stages with food information for a combination of drug information and attribute information, and the food information acquired by the information acquisition means is related to the drug information and attribute information acquired in the same way And a discriminating means for discriminating whether or not a contraindicated ingredient is contained in the information discriminating system. The information acquisition means acquires the latest biological information of the user,
The discrimination means refers to a combination contraindication degree in three or more stages with food information for a combination of drug information, attribute information and biometric information, and the food information acquired by the information acquisition means is the same drug acquired. The information discriminating system according to claim 1, further comprising: discriminating means for discriminating whether or not a contraindicated food is included in the relationship between the information, the attribute information, and the biological information. Information acquisition means for acquiring drug information taken by the user to be determined and the user's own attribute information;
A discriminating means for discriminating a contraindicated food in relation to the drug information and the attribute information acquired by the information acquiring means with reference to the combination contraindication levels of three or more stages with the food information for the combination of the drug information and the attribute information; An information discrimination system characterized by comprising: The information acquisition means acquires the latest biological information of the user,
The discriminating means refers to the combination contraindication degrees of three or more stages with the food information for the combination of the drug information, the attribute information and the biological information, and the drug information, the attribute information and the biological information acquired by the information acquiring means The information discriminating system according to claim 1, further comprising discriminating means for discriminating contraindicated foods in relation to The information acquisition means is mounted on an IC card or a portable information terminal,
The said discrimination | determination means is mounted in the discrimination | determination apparatus installed in the shop which can communicate between the said IC card or the said portable information terminal, The any one of Claims 1-4 characterized by the above-mentioned. Information discrimination system. Each information acquired by the information acquisition means is managed for each user on the cloud,
The information discrimination system according to any one of claims 1 to 5, wherein the combination contraindication level to be referred to is managed by a server that can communicate with the discrimination means. The information discrimination system according to any one of claims 1 to 6, wherein the discrimination means is controlled by artificial intelligence. The discrimination means is characterized in that information relating to the relationship of food information corresponding to contraindicated foods for a combination of drug information and attribute information is provided from the outside, and this is reflected in the combination contraindication level to be referred to. 3. The information discrimination system according to 3. The determination means is provided with information on the relationship of food information corresponding to the contraindicated food ingredients for the combination of drug information, attribute information and biometric information from the outside, and reflects this in the combination contraindication level to be referred to. Item 5. The information discrimination system according to Item 2 or 4. The information determination system according to any one of claims 1 to 9, wherein the food information includes information on a supplement scheduled to be taken by a user. An information acquisition step for acquiring information on the food to be ingested by the user to be discriminated and information on the medicine being taken, and attribute information of the user himself,
With reference to the combination contraindications of three or more levels with food information for the combination of drug information and attribute information, the food information acquired in the information acquisition step is contraindicated in the relationship with the acquired drug information and attribute information. And a discrimination step for discriminating whether or not the food is contained. An information acquisition step for acquiring drug information taken by the user to be determined and the user's own attribute information;
A discrimination step for discriminating contraindicated foods in relation to the drug information and the attribute information acquired in the information acquisition step with reference to three or more combinations of contraindications with food information for the combination of drug information and attribute information An information discrimination method characterized by comprising: An information acquisition step for acquiring information on the food to be ingested by the user to be discriminated and information on the medicine being taken, and attribute information of the user himself,
With reference to the combination contraindications of three or more levels with food information for the combination of drug information and attribute information, the food information acquired in the information acquisition step is contraindicated in the relationship with the acquired drug information and attribute information. An information discriminating program for causing a computer to execute a discriminating step for discriminating whether or not ingredients are contained. An information acquisition step for acquiring drug information taken by the user to be determined and the user's own attribute information;
A discrimination step for discriminating contraindicated foods in relation to the drug information and the attribute information acquired in the information acquisition step with reference to three or more combinations of contraindications with food information for the combination of drug information and attribute information An information discrimination program that is executed by a computer.

Images